The regularity of TVC after EGFR-TKI treatment is that the volume shrinkage gradually slows the volume continues to shrink after increasing in some cases, and tumour shrinkage varies due to the different sensitivities of EGFR-TKI treatment in different patients (32). This evidence concerns the gene EGFR and neoplasm.